文献速递腹部技术与安全CTMR

术前肝脏MRI在结肠癌同时性肝转移评估中的临床影响

Clinical impact of preoperative liver MRI in the evaluation of synchronous liver metastasis of colon cancer.
PubMed 文献 · Eur Radiol · 2018-04-24

本研究比较了术前仅行CT与额外行钆塞酸增强MRI对结肠癌同时性肝转移患者生存率的影响。结果显示,CT+MRI组5年生存率为70.8%,CT组为48.1%,且CT+MRI组总体死亡风险显著更低。额外MRI能更精确检出肝转移灶并与更好的生存率相关。

要点

  • CT+MRI组5年生存率70.8%,CT组48.1%。
  • CT+MRI组较CT组总体死亡风险显著更低。
  • MRI可检出CT initially漏诊的肝转移灶并更好显示病灶特征。

核心结论

  • 术前额外行钆塞酸增强MRI能更精确检出结肠癌同时性肝转移,并与更好的生存率相关。

研究设计与样本

  • 研究纳入52例仅行CT(CT组)和65例额外行MRI(CT+MRI组)的结肠癌同时性肝转移患者,比较5年生存率并分析影响因素,采用倾向性评分逆概率治疗加权分析调整。

关键影像表现/征象

  • CT+MRI组中44例(67.7%)CT与MRI显示的肝转移灶数目不一致。
  • MRI在26例患者中检出39个CT initially漏诊的肝转移灶。
  • CT+MRI组检出肝转移灶数目与病理结果的相关性优于CT组(p=0.008)。

诊断标准与关键数值

  • CT+MRI组估计5年生存率为70.8%,CT组为48.1%。
  • IPTW调整后多因素分析显示CT+MRI组总体死亡风险显著低于CT组。

临床应用与阅片要点

  • 术前额外行钆塞酸增强MRI有助于更精确检出结肠癌同时性肝转移灶。
  • MRI可检出CT initially漏诊的肝转移灶并更好显示病灶特征。
  • CT+MRI组可能筛选出更适合根治性治疗的患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate whether additional MRI including gadoxetic acid enhancement is associated with survival rate (SR) in patients with synchronous liver metastasis of colon cancer (sCLM), compared with patients assessed only with CT.

METHODS: Fifty-two patients underwent only CT (CT group) and 65 underwent additional MRI (CT+MRI group) for preoperative work-up of sCLM. In the CT+MRI group, the discrepancy between CT and MRI was analyzed. The 5-year SR was compared between the groups, and affecting factors were investigated. The inverse probability treatment weighting analysis (IPTW) adjusted by propensity scores was performed.

RESULTS: In the CT+MRI group, 44 (67.7%) showed a discrepancy in the number of sCLMs between CT and MRI. MRI detected 39 additional sCLMs initially missed on CT in 26 patients. The number of detected sCLMs was better correlated with the pathologic findings in the CT+MRI group than in the CT group (p = 0.008). The estimated 5-year SR in the CT+MRI group was 70.8%, while that in the CT group was 48.1%. On adjusted multivariate analyses after the IPTW, the CT+MRI group showed a significantly lower risk of overall mortality than the CT group.

CONCLUSION: Additional preoperative evaluation by MRI allowed us to more precisely detect sCLM and was associated with a better SR.

KEY POINTS: • CT+MRI group showed significantly higher 5-year survival rates than CT group. • CT+MRI group was an independent prognostic factor of overall mortality. • MRI facilitates more accurate detection and better lesion characterization. • MRI selected better candidates for curative treatment. • The benefits of MRI were reflected by better survival.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Kim C, Kim SY, Kim MJ, et al. Clinical impact of preoperative liver MRI in the evaluation of synchronous liver metastasis of colon cancer. Eur Radiol. 2018. PMID: 29691635. doi:10.1007/s00330-018-5422-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。